维普期刊资源整合服务平台（V6.5）

260篇 您的检索式：作者名="Zatloukal P"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non small cell lung cancer: a randomized study 显示文摘	Zatloukal P Petruzelka L Zemanova M	2004	Lung Cancer2004，46，1：	1
2	Phase III trial of cispl-atin plus gemcitabine with either placebo or bevacizumab asfirst-line therapy for nonsquamous non-small-cell lung cancer:Avail显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
3	Final safety results of BO17704(A-VAiL):a phase III randomized study of first-line bevacizumab(BV)and cisplatin/gemcitabine(CG)in patients(pts)with ad-vanced or recurrent nonsquamous non-small cell lung cancer(NSCLC)显示文摘	Hirsh V Ramlau R von Pawel J Zatloukal P Vera G Leighl N Mezger J Archer V Reck M	2009	J Clin Oncol2009，，：	1
4	PhaseⅢtrial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-smallcell lung cancer:AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
5	A multicenter interna-tional randomized phaseⅢstudy comparing Cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease显示文摘	Zatloukal P Cardenal F Szozesna A	2010	Ann Oncol2010，12，9：	1
6	Gemcitabine plus cis- platin vs gemcitabine plus carboplatin in stage Ⅲ b or IV non -small cell lung cancer: a phase Ⅲ randomized trial 显示文摘	Zatloukal P Petruzelka L Zemanova M	2003	Lung Cancer2003，41，3：	1
7	A multicenter internationalrandomized phaseⅢ study comparing Cisplatin in combination withIrinotecan or Etoposide in previously untreated small-cell lung can-cer patients with extensive disease显示文摘	Zatloukal P Cardenal F Szczesna A	2010	Ann Oncol2010，12，9：	1
8	Overall survival with cispl- atin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAIL)显示文摘	Reck M yon Pawel J Zatloukal P	2010	Ann Oncol2010，21，9：	1
9	PhaseⅢ trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer:AVAil显示文摘	Reck M von Pawel J Zatloukal P		0，，：	1
10	Gemcitabine in non-small-cell lung cancer显示文摘	Manegold C Zatloukal P Krejcy k	2000	Invest New Drugs2000，18，1：	1
11	Gemcitabine in non-small cell lung cancer(NSCLC) 显示文摘	Manegold C Zatloukal P Krejcy K	2000	Invest New Drugs2000，18，1：	1
12	Phase El trial of cispl-atin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
13	Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study 显示文摘	Zatloukal P Petruzelka L Zenmnova M	2004	Lung Cancer2004，46，1：	1
14	A multicenter international randomized phaseⅢstudy comparing Cisplatin in combination with Irinotecan or Etoposide in previously untreated small-cell lung cancer patients with extensive disease显示文摘	Zatloukal P Cardenal F Szczesna A	2010	Ann Oncol2010，12，9：	1
15	concurrent chemoradiotherapy versus sequential radiotherapy with cisplatin and vinorelbine in locally advanced non-small celt lung cancer: A randomized study显示文摘	Zatloukal P Petruzelka L Zemanova M	2004	Lung Cancer2004，46，：	1
16	Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer:randomized study显示文摘	Zatloukal P Petruzelka L Zemanova M	2004	Lung Cancer2004，46，1：	1
17	Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study 显示文摘	Zatloukal P Petruzelka L Zemanova M	2004	Lung Cancer2004，46，1：	1
18	Efficacy and safety of bevaci zumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase Ⅲ BO17704 study (AVAiL)显示文摘	Leighl NB Zatloukal P Mezger J	2010	J Thorac Oncol2010，5，12：	1
19	Gemcitabine in non-small-cell lung cancer显示文摘	Zatloukal P Krejcy K	2000	Invest New Drugs2000，18，1：	1
20	Multicenter phase Ⅱ trial of YM155,a small-molecule suppressor of survivin,in patients with advanced,refractory,non-small-cell lung cancer显示文摘	Giaccone G Zatloukal P Roubec J	2009	J Clin Oncol2009，27，27：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示